Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-06-01
著者
-
NAKAMOTO Yasunari
Department of Disease Control and Homeostasis, Graduate School of Medicine, Kanazawa University
-
Nishiguchi Shuhei
Division Of Hepatobiliary And Pancreatic Disease Department Of Internal Medicine Hyogo College Of Me
-
Shiota Goshi
Division Of Molecular And Genetic Medicine Department Of Genetic Medicine And Regenerative Therapeut
-
Takehara Tetsuo
Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine
-
MIYAYAMA Shiro
Department of Diagnostic Radiology, Fukuiken Saiseikai Hospital
-
Kaneko Shuichi
Department Of Cancer Gene Regulation Kanazawa University
-
Miyayama Shiro
Department Of Diagnostic Radiology Fukuiken Saiseikai Hospital
-
Moriwaki Hisataka
Department Of Gastroenterology And Hematology Division Of Organ Pathobiology Gifu University School
-
Sata Michio
Division Of Clinical Nutrition Shiga University Of Medical Science
-
Ueno Yoshiyuki
Department Of Gastroenterology Division Of Internal Medicine Tohoku University Graduate School Of Me
-
Hiroishi Kazumasa
Division Of Gastroenterology Department Of Medicine Showa University School Of Medicine
-
Sakaida Isao
Department Of Gastroenterology & Hepatology School Of Medicine Yamaguchi University
-
Yamamoto Kazuhide
Department Of Electrical Engineering Nagaoka University Of Technology
-
Ikeda Kenji
Department De Genie Chimique Universite Nationale De Yokohama
-
Furuse Junji
Department Of Internal Medicine Medical Oncology Kyorin University School Of Medicine
-
Imai Yukinori
Department Of Gastroenterology And Hepatology Faculty Of Medicine Saitama Medical University
-
OBI Shuntaro
Department of Gastroenterology and Hepatology, Kyoundo Hospital
-
NISHIGUCHI Shuhei
Division of Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo College of Medicine
-
KUDO Masatoshi
Department of Gastroenterology, Kinki University
-
YOKOSUKA Osamu
Department of Gastroenterology and Clinical Oncology, Graduate School of Medicine, Chiba University
-
HONDA MASAO
Department of Anatomy II, Fukushima Medical University School of Medicine
-
Kudo Masatoshi
Department of Clinical Molecular Medicine, Division of Diabetes, Digestive and Kidney Diseases
-
ONCHI Morikazu
Department of Gastroenterology and Metabology, Graduate School of Medicine, Ehime University
-
FURUSE Junji
Department of Medical Oncology, Kyorin University School of Medicine
-
SHIOTA Goshi
Division of Molecular and Genetic Medicine, Tottori University Graduate School of Medicine
-
NAKAMOTO Yasunari
Department of Gastroenterology, Graduate School of Medicine, Fukui University
-
OBI Shuntaro
Department of Hepatology, Kyoundo Hospital
関連論文
- Reactive peripheral blood plasmacytosis in a patient with acute hepatitis A
- Involvement of thioredoxin-binding protein 2 in the antitumor activity of CD437
- Hepatitis B virus X protein overcomes oncogenic RAS-induced senescence in human immortalized cells
- Virological effects and safety of combined double filtration plasmapheresis (DFPP) and interferon therapy in patients with chronic hepatitis C: A preliminary study
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Inhibition of Inward Rectifier K^+ Currents by Angiotensin II in Rat Atrial Myocytes : Lack of Effects in Cells from Spontaneously Hypertensive Rats
- Effects of Angiotensin II on the Action Potential Durations of Atrial Myocytes in Hypertensive Rats
- Developmental Changes of Ni^ Sensitivity and Automaticity in Nkx2.5-Positive Cardiac Precursor Cells From Murine Embryonic Stem Cell
- State-Dependent Blocking Actions of Azimilide Dihydrochloride (NE-10064) on Human Cardiac Na^+ Channels
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis : A prospective, multicenter study
- The committee for revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma
- Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease
- Apoptosis of murine cultured biliary epithelial cells induced by glycochenodeoxycholic acid involves Fas receptor and its ligand
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
- Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
- Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection
- Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
- The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
- Juvenile hepatocellular carcinoma with congestive liver cirrhosis
- Changes in gene expression profile by HCV core protein in cultured liver cells : analysis by DNA array assay
- Selective estrogen receptor modulator raloxifene-associated aggravation of nonalcoholic steatohepatitis.
- Transformation of p53-positive papillary thyroid carcinoma to anaplastic carcinoma of the liver following postoperative radioactive iodine-131 therapy
- Genetic analysis of expression profile involved in retinoid metabolism in non-alcoholic fatty liver disease
- LIVING-RELATED LIVER TRANSPLANTATION FOR PEDIATRIC PATIENTS(International Symposium ,第29回日本小児外科学会総会)
- Crucial role of impaired Kupffer cell phagocytosis on the decreased Sonazoid-enhanced echogenicity in a liver of a nonalchoholic steatohepatitis rat model
- Restoration of gut motility in Kit-deficient mice by bone marrow transplantation
- Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
- Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K_2
- Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene
- Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
- α-ガラクトシルセラミドをパルスした樹状細胞の肝内投与により肝腫瘍は抑制される
- Hepatic differentiation of human bone marrow-derived UE7T-13 cells : Effects of cytokines and CCN family gene expression
- Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer
- The liver as a target organ of retinoids
- Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor
- Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus
- Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease : A case-control study
- Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection?
- TRENDS IN THE CAUSES AND OUTCOME OF LIVER CIRRHOSIS DIAGNOSED BY LAPAROSCOPY IN OSAKA, JAPAN DURING THE PAST THREE DECADES
- Histopathological findings after ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma
- Focal hepatic lesions mimicking cavernous hemangioma supplied by the portal vein
- Lack of mitochondrial DNA enhances growth of hepatocellular carcinoma in vitro and in vivo
- Potential role of vitamin K_2 as a chemopreventive agent against hepatocellular carcinoma
- Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment : comparison with three other assays
- Influence of interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma
- Hepatocyte growth factor mobilizes and recruits hematopoietic progenitor cells into liver through a stem cell factor-mediated mechanism
- Antiviral therapy for chronic hepatitis C : past, present, and future
- Etiology of liver cirrhosis in Japan : a nationwide survey
- A New Epitope of CYP2D6 Recognized by Liver Kidney Microsomal Autoantibody from Japanese Patients with Autoimmune Hepatitis(Pharmacology)
- Transient Expression of Bone Morphogenic Protein-2 in Acute Liver Injury by Carbon Tetrachloride
- Fas and Fas ligand in human hepatocellular carcinoma
- Vitamin K2 downregulates the expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma cells
- Hepatoma-derived growth factor is induced in liver regeneration
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- The hypothesis of Warburg revisited : A metabolic switch in carcinogenesis
- STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo
- Adipocytokines and liver disease
- Molecular Pathogenesis of Viral Hepatitis
- Interventional oncology : new options for interstitial treatments and intravascular approaches : Superselective TACE using iodized oil for HCC : rationale, technique and outcome
- A new way to deplete Kupffer cells
- Bcl-xL阻害薬ABT-737はソラフェニブと併用した時に肝癌細胞のアポトーシスを誘導し増殖を抑制する
- Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet
- Iron state in association with retinoid metabolism in non-alcoholic fatty liver disease
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- A Close Association of Abnormal Iron Metabolism with Steatosis in the Mice Fed a Choline-Deficient Diet
- The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
- c-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor α protein in hepatic cells
- Disrupted plasma membrane localization of equilibrative nucleoside transporter 2 in the chemoresistance of human pancreatic cells to gemcitabine (dFdCyd)
- Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
- Differential alteration of CD56^ and CD56^ natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection
- Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels : a matched case-control study
- Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
- Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
- Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin
- Reply to the letter by L. Czako et al. regarding "Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia : a multicenter study by Osaka University ESD Study Group"
- Hepatitis B virus reactivation associated with temozolomide for malignant glioma : a case report and recommendation for prophylaxis
- Clinical Characteristics of Patients who Developed Hepatocellular Carcinoma after Hepatitis C Virus Eradication with Interferon Therapy: Current Status in Japan
- Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
- Progress in stem cell biology in regenerative medicine for liver disease
- Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update
- Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma
- Anticarcinogenic impact of interferon therapy on the propression of hepatocellular carcinoma in patients with chronic viral infection
- Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines
- Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection
- Adiponectin negatively correlates with alcoholic and non-alcoholic liver dysfunction : Health check-up study of Japanese men
- Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis
- Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011
- Conditional knockout of heparin-binding epidermal growth factor-like growth factor in the liver accelerates carbon tetrachloride-induced liver injury in mice